Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is one of the 13 Biotech Stocks with Huge Upside Potential.
Keep Reading →
June 11 - News
The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce reductions.
Keep Reading →
June 11 - Hedge Funds, News
On June 3, Needham analyst Ami Fadia reaffirmed a Buy rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) and raised the price target slightly from $200 to $202.
Keep Reading →
June 4 - News
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) announced today that the Phase 3 IMforte trial has established a new milestone in the treatment of extensive-stage small cell lung cancer...
Keep Reading →
June 3 - News
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2025 Earnings Call Transcript May 6, 2025Jazz Pharmaceuticals plc misses on earnings expectations.
Keep Reading →
May 8 - News, Transcripts
Up until February 18, 2025, the stock market seemed poised to replicate the 2020-2022 bull run.
Keep Reading →
May 6 - Hedge Funds, News
On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC's 'Power Lunch' to discuss investing in biotech and the oversaturation in the sector.
Keep Reading →
March 26 - Hedge Funds, Industries, News
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Keep Reading →
March 24 - Hedge Funds, News
Cash flow is the money moving in and out of a business over a set period.
Keep Reading →
March 3 - Hedge Funds, News
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2024 Earnings Call Transcript February 25, 2025Jazz Pharmaceuticals plc misses on earnings expectations.
Keep Reading →
February 26 - News, Transcripts
After two years of substantial gains to record highs, exhaustion in the US equity markets is slowly kicking in.
Keep Reading →
January 15 - Hedge Funds, News
A decade ago, the cannabis industry was in full swing as stock valuations exploded to record highs in states across the country legalizing pot use for medicinal and recreational...
Keep Reading →
November 27 - Hedge Funds, News
Silver Ring Value Partners, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
November 19 - Hedge Fund Investor Letters, News
The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by 2033.
Keep Reading →
November 18 - Hedge Funds, News
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2024 Earnings Call Transcript November 6, 2024Jazz Pharmaceuticals plc beats earnings expectations.
Keep Reading →
November 8 - News, Transcripts
The broader market reached new record highs on October 11, driven by financial stocks posting stronger-than-expected quarterly results.
Keep Reading →
October 27 - Hedge Funds, News
Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.
Keep Reading →
October 11 - Hedge Funds, Industries, News
The start of October has seen another wild swing for markets.
Keep Reading →
October 8 - News
Analysts and the market blamed the Fed for not cutting the interest rate earlier in July.
Keep Reading →
October 8 - Hedge Funds, News
Today's AI-fueled era of the "Magnificient Seven" technology stocks is dominating the US stock market.
Keep Reading →
October 8 - Hedge Funds, News
The US equities saw a strong move after the September jobs report exceeded the economists’ estimates.
Keep Reading →
October 6 - Hedge Funds, News
Seth Klarman, the founder and CEO of Baupost Group, is a prominent figure in the investment industry, with his hedge fund ranking as the 12th largest globally.
Keep Reading →
October 3 - Hedge Funds, News
The current market data shows that the economy of the United States is normalizing, especially with an active Federal Reserve, global stimulus from China, and higher consumption...
Keep Reading →
September 30 - Hedge Funds, News
According to projections by ReportLinker, the market for healthcare services will increase from $7.5 trillion in 2022 to $7.975 trillion in 2023.
Keep Reading →
September 2 - Hedge Funds, Industries, News
Diversifying an investment portfolio is one of the best ways of spreading risk and minimizing the impact of heightened volatility.
Keep Reading →
August 26 - Hedge Funds, News
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q2 2024 Earnings Call Transcript July 31, 2024Jazz Pharmaceuticals plc misses on earnings expectations.
Keep Reading →
August 1 - News, Transcripts
The history of the cannabis industry is riddled with changes and conflicting legislation.
Keep Reading →
June 29 - Hedge Funds, Industries, News, Stock Analysis
Operator: Thank you for standing by. My name is Krista, and I will be your conference operator today.
Keep Reading →
May 7 - News, Transcripts
For years, investors have chased the latest tech darlings, throwing money at overvalued companies based on hype and empty promises.
Keep Reading →
April 4 - Hedge Fund Investor Letters, News
In this piece, we will take a look at the five high growth value stocks to invest in according to Seth Klarman.
Keep Reading →
March 28 - Hedge Funds, News
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Keep Reading →
March 17 - Lists, News
Satellite communication and internet services company EchoStar Corp (NASDAQ:SATS) ranks fifth in our list of the stocks with the highest insider purchasing activity recently.
Keep Reading →
March 12 - Insider Trading, News
In this article, we will take a look at the 5 biotech stocks with huge potential.
Keep Reading →
March 8 - Hedge Funds, News
This article presents an overview of the 5 Mid-Cap Stocks with Insider Purchases. For a detailed overview of such stocks, read our article, 10 Mid-Cap Stocks with Insider Purchases...
Keep Reading →
March 7 - Insider Trading, News
Jazz Pharmaceuticals plc misses on earnings expectations. Reported EPS is $5.02 EPS, expectations were $5.26.
Keep Reading →
February 29 - News, Transcripts
In this article, we discuss 5 best marijuana stocks to invest in.
Keep Reading →
February 22 - News
In this piece, we will take a look at the five most promising stocks to buy according to hedge funds.
Keep Reading →
December 27 - Hedge Funds, News
In this piece, we will take a look at the five best upside stocks to buy right now.
Keep Reading →
November 27 - Hedge Funds, News
Innovative Industrial Properties, Inc.
Keep Reading →
November 26 - Hedge Funds, News
In this article, we discuss billionaire Seth Klarman’s top 4 biotech stock picks.
Keep Reading →
November 22 - Hedge Funds, News
In this piece, we will take a look at the 12 best value stocks picked by Seth Klarman to buy heading into 2024. If you want to skip.
Keep Reading →
November 14 - Hedge Funds, News
Operator: Good afternoon. My name is Krista, and I'll be your conference operator today.
Keep Reading →
November 9 - News, Transcripts
Investors remain anxious about the Fed’s next move and the upcoming policy decision as they continue to process consumer data to get hints on inflation’s trajectory.
Keep Reading →
October 31 - Hedge Funds, News
In this piece, we will take a look at the five most undervalued pharmaceutical stocks to buy according to analysts.
Keep Reading →
October 30 - Hedge Funds, News
In this piece, we will take a look at the 11 best long term stocks to buy for high returns.
Keep Reading →
October 30 - Hedge Funds, News
In this article, we discuss 11 of the best immunotherapy stocks to buy now.
Keep Reading →
October 30 - Hedge Funds, News
In this article, we shall cover the top 30 oncology companies in the world.
Keep Reading →
October 13 - Business, Hedge Funds, Lists, News
Aristotle Capital Management, LLC, an investment management company, released its “Global Equity Strategy” third quarter 2023 investor letter.
Keep Reading →
October 13 - Hedge Fund Investor Letters, News
In this article, we discuss 14 best cancer stocks to buy.
Keep Reading →
October 9 - Hedge Funds, News
In this article, we looked at what billionaire Seth Klarman thinks about the stock market outlook, his investing principles, and what he recommends to investors.
Keep Reading →
October 4 - Hedge Fund Analysis, News